Earth is hit by asteroids all the time, but to avoid severe damages in the future NASA's Double Asteroid Redirection Test ...

Aktis Oncology’s IPO will support a pipeline of “miniprotein” radioconjugates that could offer advantages over other targeted ...

No IPOs are currently scheduled in the week ahead, although smaller issuers may join the calendar throughout the week. Read ...

According to the registration form, Aktis intends to use a large portion of the IPO proceeds on the two programmes. Around ...

Today, Science, Technology, and Innovation are increasingly important in all spheres of human life. As science and technology rapidly advance, some developing nations are seizing the opportunity to ...

11-inch IPS touchscreen with crisp 1080P resolution Sony STARVIS image sensor with an F1.0 aperture for excellent low-light performance. Dual 2K cameras with optional 1080p third-channel recording.

Aktis Oncology (AKTS), a radiopharmaceutical drug developer backed by pharma giants such as Eli Lilly (LLY), has filed its preliminary regulatory filings with the Securities and Exchange Commission ...

Big Pharma-backed Aktis Oncology has announced plans to go public, in the latest encouraging sign for those betting on a resurgence in biotech IPOs next year. Aktis saw the likes of Bristol Myers ...

Valentina Fantasia receives funding from The Wallenberg AI, Autonomous Systems and Software Program – Humanity and Society (WASP-HS). She is affiliated with the Department of Philosophy and Cognitive ...

As part of President Trump’s trip to Asia, the United States signed Technology Prosperity Deals (TPD) with Japan and Korea, expanding, strengthening, and focusing science and technology collaboration ...

The Government of the United States of America, represented by the Office of Science and Technology Policy, and the Government of Japan, represented by the Cabinet Office of Japan for the purposes of ...

Once again, AI dominates the agenda when it comes to discussing the most significant and impactful trends of the coming year. But with 2026 fast approaching, the conversation isn’t just around what AI ...